Company Financials

Protagonist Therapeutics, Inc. Financials

United States dollar

business Protagonist Therapeutics, Inc. Company Profile

Main Stock Listing

NASDAQ: PTGX

Market Capitalization $5.45 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 132.33
Forward PE 82.30
Price to Sales TTM $26.10
Price to Book MRQ $8.45
Enterprise to Revenue 23.40
Enterprise to EBITDA 244.37

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 21.94%
Operating Margin -985.17%
Return on Assets TTM 1.82%
Return on Equity TTM 7.80%

Income Statement

Revenue TTM $209,216,992
Revenue per Share TTM $3.31
Quarterly Revenue Growth 0.80%
Gross Profit TTM $209,216,992
EBITDA $255,738,000
Net Income to Common TTM $45,909,000
Diluted EPS TTM $0.66
Quarterly Earnings Growth YoY 0.79%

Balance Sheet

Total Cash MRQ $576,116,992
Total Cash per Share MRQ $9.22
Total Debt MRQ $
Total Debt to Equity MRQ 1.67
Current Ratio MRQ 13.05
Book Value per Share MRQ $10.34

Cash Flow

Operating Cash Flow TTM $65,468,000
Levered Free Cash Flow TTM $53,095,000

PTGX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 62,447,102
Float Shares 49,893,128
Avg 10 Volume 765,280
Avg 30 Volume None
Shares Short 6,539,025
Short Ratio 6.62
Short % of Shares 12.53%
% Held by Insiders 1.01%
% Held by Institutions 115.95%

Stock Price Summary

Beta 2.19
Fifty Two Week Low $33.70
Fifty Two Week High $96.54
Fifty Two Week Change 56.31%
Day 50 MA $84.64
Day 200 MA $61.83

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date